Showing results (51-60 of 901) with videos related to
Sort By:
Pageof 91
Journal of Hepatology|March 9, 2010
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspectiveJerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn, et al.United European Gastroenterology Journal|March 28, 2020
Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascitesMarie Schultalbers, Tammo L Tergast, Nicolas Simon, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis EJana Al-Ayoubi, Patrick Behrendt, Birgit Bremer, et al.Antiviral Therapy|September 9, 2011
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analoguesJerzy Jaroszewicz, Huy Ho, Antoaneta Markova, et al.Gastroenterology Clinics of North America|April 15, 2004
Adherence to combination therapy: influence on sustained virologic response and economic impactMichael P MannsSeminars in Liver Disease|November 26, 2002
Current state of interferon therapy in the treatment of chronic hepatitis BMichael P MannsZeitschrift Fur Gastroenterologie|April 16, 2013
[50 years of hepatology - from therapeutic nihilism to targeted therapies]Michael P MannsHepatology (Baltimore, Md.)|January 28, 2006
Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II studyJohannes Wiegand, Peter Buggisch, Wulf Boecher, et al.Plos One|February 6, 2013
Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world settingBenjamin Maasoumy, Kerstin Port, Antoaneta Angelova Markova, et al.Annals of Gastroenterology|April 16, 2014
The role of HBsAg levels in the current management of chronic HBV infectionChristoph Höner Zu Siederdissen, Markus CornbergPageof 91